Search Results - "European journal of neurology"

Amyotrophic lateral sclerosis: a clinical review by Masrori, P., Van Damme, P.

“…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting primarily the motor system, but in which extra‐motor manifestations are…”
Get full text

Parkinson disease by Balestrino, R., Schapira, A.H.V.

“…Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately…”
Get full text

Multiple sclerosis – a review by Dobson, R., Giovannoni, G.

“…Multiple sclerosis (MS) is the commonest non‐traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the…”
Get full text

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision by Van den Bergh, Peter Y. K., Doorn, Pieter A., Hadden, Robert D. M., Avau, Bert, Vankrunkelsven, Patrik, Allen, Jeffrey A., Attarian, Shahram, Blomkwist‐Markens, Patricia H., Cornblath, David R., Eftimov, Filip, Goedee, H. Stephan, Harbo, Thomas, Kuwabara, Satoshi, Lewis, Richard A., Lunn, Michael P., Nobile‐Orazio, Eduardo, Querol, Luis, Rajabally, Yusuf A., Sommer, Claudia, Topaloglu, Haluk A.

“…Objective To revise the 2010 consensus guideline on chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods Seventeen disease experts, a…”
Get full text

European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness by Kondziella, D., Bender, A., Diserens, K., van Erp, W., Estraneo, A., Formisano, R., Laureys, S., Naccache, L., Ozturk, S., Rohaut, B., Sitt, J. D., Stender, J., Tiainen, M., Rossetti, A. O., Gosseries, O., Chatelle, C.

“…Background and purpose Patients with acquired brain injury and acute or prolonged disorders of consciousness (DoC) are challenging. Evidence to support…”
Get full text

Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study by Beltrán‐Corbellini, Á., Chico‐García, J. L., Martínez‐Poles, J., Rodríguez‐Jorge, F., Natera‐Villalba, E., Gómez‐Corral, J., Gómez‐López, A., Monreal, E., Parra‐Díaz, P., Cortés‐Cuevas, J. L., Galán, J. C., Fragola‐Arnau, C., Porta‐Etessam, J., Masjuan, J., Alonso‐Cánovas, A.

“…Background and purpose Specific respiratory tract infections, including COVID‐19, may cause smell and/or taste disorders (STDs) with increased frequency. The…”
Get full text

Huntington's disease: a clinical review by McColgan, P., Tabrizi, S. J.

“…Huntington's disease (HD) is a fully penetrant neurodegenerative disease caused by a dominantly inherited CAG trinucleotide repeat expansion in the huntingtin…”
Get full text

European Academy of Neurology guideline on trigeminal neuralgia by Bendtsen, L., Zakrzewska, J. M., Abbott, J., Braschinsky, M., Di Stefano, G., Donnet, A., Eide, P. K., Leal, P. R. L., Maarbjerg, S., May, A., Nurmikko, T., Obermann, M., Jensen, T. S., Cruccu, G.

“…Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are…”
Get full text

European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome by Doorn, Pieter A., Van den Bergh, Peter Y. K., Hadden, Robert D. M., Avau, Bert, Vankrunkelsven, Patrik, Attarian, Shahram, Blomkwist‐Markens, Patricia H., Cornblath, David R., Goedee, H. Stephan, Harbo, Thomas, Jacobs, Bart C., Kusunoki, Susumu, Lehmann, Helmar C., Lewis, Richard A., Lunn, Michael P., Nobile‐Orazio, Eduardo, Querol, Luis, Rajabally, Yusuf A., Umapathi, Thirugnanam, Topaloglu, Haluk A., Willison, Hugh J.

“…Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory…”
Get full text

Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models by Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., Pisani, A.

“…The current coronavirus disease (COVID‐19) outbreak, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has raised the…”
Get full text

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology by Ferro, J. M., Bousser, M.‐G., Canhão, P., Coutinho, J. M., Crassard, I., Dentali, F., Minno, M., Maino, A., Martinelli, I., Masuhr, F., Aguiar de Sousa, D., Stam, J.

“…Background and purpose Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological…”
Get full text

Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection: A longitudinal prospective study nested to a population cohort by Del Brutto, Oscar H., Wu, Shasha, Mera, Robertino M., Costa, Aldo F., Recalde, Bettsy Y., Issa, Naoum P.

“…Background and purpose Neurological complications of SARS‐CoV‐2 infection are noticed among critically ill patients soon after disease onset. Information on…”
Get full text

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study by Rass, Verena, Beer, Ronny, Schiefecker, Alois Josef, Kofler, Mario, Lindner, Anna, Mahlknecht, Philipp, Heim, Beatrice, Limmert, Victoria, Sahanic, Sabina, Pizzini, Alex, Sonnweber, Thomas, Tancevski, Ivan, Scherfler, Christoph, Zamarian, Laura, Bellmann‐Weiler, Rosa, Weiss, Günter, Djamshidian, Atbin, Kiechl, Stefan, Seppi, Klaus, Loeffler‐Ragg, Judith, Pfausler, Bettina, Helbok, Raimund

“…Background and purpose To assess neurological manifestations and health‐related quality of life (QoL) 3 months after COVID‐19. Methods In this prospective,…”
Get full text

Encephalitis as a neurological complication of COVID‐19: A systematic review and meta‐analysis of incidence, outcomes, and predictors by Siow, Isabel, Lee, Keng Siang, Zhang, John J. Y., Saffari, Seyed Ehsan, Ng, Adeline

“…Background and purpose Although COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders…”
Get full text

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial by Ashina, Messoud, Goadsby, Peter J., Reuter, Uwe, Silberstein, Stephen, Dodick, David W., Xue, Fei, Zhang, Feng, Paiva da Silva Lima, Gabriel, Cheng, Sunfa, Mikol, Daniel D.

“…Background and purpose Although erenumab has demonstrated significant reduction in migraine frequency and improved quality of life in studies lasting 3 to…”
Get full text

Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown by Lara, B., Carnes, A., Dakterzada, F., Benitez, I., Piñol‐Ripoll, G.

“…Background and purpose The COVID‐19 epidemic is affecting almost all individuals worldwide, and patients with Alzheimer’s disease (AD) and amnesic mild…”
Get full text

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis by Montalban, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., Selmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H., Zipp, F.

“…Background and purpose Multiple sclerosis (MS) is a complex disease with new drugs becoming available in the past years. There is therefore a need for a…”
Get full text

Monogenic cerebral small‐vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology by Mancuso, M., Arnold, M., Bersano, A., Burlina, A., Chabriat, H., Debette, S., Enzinger, C., Federico, A., Filla, A., Finsterer, J., Hunt, D., Lesnik Oberstein, S., Tournier‐Lasserve, E., Markus, H. S.

“…Background and purpose Guidelines on monogenic cerebral small‐vessel disease (cSVD) diagnosis and management are lacking. Endorsed by the Stroke and…”
Get full text

Stroke care during the COVID‐19 pandemic: experience from three large European countries by Bersano, A., Kraemer, M., Touzé, E., Weber, R., Alamowitch, S., Sibon, I., Pantoni, L.

“…In order to cope with the exponentially increasing number of patients infected with SARS‐CoV‐2, European countries made enormous efforts to reorganize medical…”
Get full text

Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysis by Baldini, Tommaso, Asioli, Gian Maria, Romoli, Michele, Carvalho Dias, Mariana, Schulte, Eva C., Hauer, Larissa, Aguiar De Sousa, Diana, Sellner, Johann, Zini, Andrea

“…Background and purpose Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection predisposes patients to arterial and venous thrombosis. This…”
Get full text